痰热清注射液治疗急性支气管炎临床疗效研究

《痰热清注射液治疗急性支气管炎临床疗效研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、提要目的：本课题主要研究痰热清注射液治疗急性支气管炎的临床疗效。方法：将80例急性支气管炎患者随机分为痰热清组和常规治疗组，痰热清组为在对照组常规治疗的基础上，加用痰热清注射液20ml静脉滴注，1天1次，疗程5-7天。观察两组治疗前后发热、咳嗽、咯痰、舌苔、脉象、肺部体征、肺部X线和血液分析等主要临床症状、体征评分和改善时间。结果：临床研究显示，痰热清组与常规治疗组临床症状疗效分别为痊愈率45.00%、27.5%，显效32.50%、22.50%；有效20.00%、32.50%;无效2.50%、17.50%;总有效率97.50%、90.00%。两组总疗效比较P<0.

2、05有显著性差异，痰热清组临床症状疗效优于对照组。结论：痰热清治疗急性支气管炎具有良好的治疗作用，能显著改善临床症状，并可明显缩短治疗时间。关键词急性支气管炎；痰热清注射液；疗效ClinicalcurativeeffectstudyofTanreqinginjectionforacutebronchitisSpeciality:InternalMedicineofTraditionalChineseMedicineMedicineAuthor:SunLizhiTutor:ProfessorLiuShiqingAbstractObjective:Thistopicw

3、asmainresearchTanreqinginjectionacutebronchitisclinicalcurativeeffect.Methods:80casesofpatientswithacutebronchitisrandomlydividedintoTanreqinggroupandtheroutinetreatmentgroup,Tanreqinggroupinthecontrolgroupforconventionaltreatmentbasedon,addwithtanreqinginjection20mlclearinjectionintr

4、avenousinjection,1day1,thetreatment5-7days.Watchtwogroupsbeforeandaftertreatmentfever,cough,coughupphlegm,coatingonthetongue,pulsecondition,andpulmonarysigns,lungXlineandbloodanalysisandothermajorclinicalsymptoms,signsscoreandimprovethetime.Results:Thetreatmentgroupcurativeeffectsurpa

5、ssesthecomparisonlineobviously,compareswiththecontrolgroup,treatmentgroupcurativeeffectdistinctenhancement(after,examination,P<0.05).Conclusions:Tanreqinginjectioncleartreatmentacutebronchitiscurativeeffectisaccurate.Keywordacutebronchitis;TanreqingInjection;Curativeeffect目录引言........

6、......................................................................................................................1临床研究................................................................................................................................3一、临床资料...........................

7、.............................................................................................3（一）病例来源....................................................................................................................3（二）病历选择标准..........................................................

8、.....